Hansoh Pharmaceutical Group Co Ltd has re-filed its application to conduct an initial public offering (IPO) in Hong Kong that could fetch the Chinese drug-maker at least $500 million, people with direct knowledge of the matter said on Friday.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
